432 related articles for article (PubMed ID: 31075939)
1. Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells.
Singh S; Chakrabarti R
J Clin Med; 2019 May; 8(5):. PubMed ID: 31075939
[TBL] [Abstract][Full Text] [Related]
2. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
4. EMT-induced immune evasion: connecting the dots from mechanisms to therapy.
Imodoye SO; Adedokun KA
Clin Exp Med; 2023 Dec; 23(8):4265-4287. PubMed ID: 37966552
[TBL] [Abstract][Full Text] [Related]
5. Breast tumor cell-specific knockout of
Xu Y; Lee DK; Feng Z; Xu Y; Bu W; Li Y; Liao L; Xu J
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11494-11499. PubMed ID: 29073077
[TBL] [Abstract][Full Text] [Related]
6. Roles of genetic and microenvironmental factors in cancer epithelial-to-mesenchymal transition and therapeutic implication.
Yang L; Shang Z; Long S; Wang N; Shan G; Zhang R
Exp Cell Res; 2018 Sep; 370(2):190-197. PubMed ID: 30075173
[TBL] [Abstract][Full Text] [Related]
7. Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells.
Li QQ; Xu JD; Wang WJ; Cao XX; Chen Q; Tang F; Chen ZQ; Liu XP; Xu ZD
Clin Cancer Res; 2009 Apr; 15(8):2657-65. PubMed ID: 19336515
[TBL] [Abstract][Full Text] [Related]
8. Impact of Epithelial-Mesenchymal Transition on the Immune Landscape in Breast Cancer.
Khadri FZ; Issac MSM; Gaboury LA
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680248
[TBL] [Abstract][Full Text] [Related]
9. [Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].
Fang WG; Tian XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):188-195. PubMed ID: 28416823
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
11. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1-Induced Epithelial-Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells.
Johansson J; Tabor V; Wikell A; Jalkanen S; Fuxe J
Front Oncol; 2015; 5():3. PubMed ID: 25674539
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
[TBL] [Abstract][Full Text] [Related]
14. Understanding the Complex Milieu of Epithelial-Mesenchymal Transition in Cancer Metastasis: New Insight Into the Roles of Transcription Factors.
Imodoye SO; Adedokun KA; Muhammed AO; Bello IO; Muhibi MA; Oduola T; Oyenike MA
Front Oncol; 2021; 11():762817. PubMed ID: 34868979
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
Martins-Lima C; Chianese U; Benedetti R; Altucci L; Jerónimo C; Correia MP
Front Mol Biosci; 2022; 9():1070383. PubMed ID: 36699696
[TBL] [Abstract][Full Text] [Related]
16. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
17. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
[TBL] [Abstract][Full Text] [Related]
18. Permissive State of EMT: The Role of Immune Cell Compartment.
Fedele V; Melisi D
Front Oncol; 2020; 10():587. PubMed ID: 32391271
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines.
Kondaveeti Y; Guttilla Reed IK; White BA
Cancer Lett; 2015 Aug; 364(1):44-58. PubMed ID: 25917568
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior.
Savci-Heijink CD; Halfwerk H; Hooijer GKJ; Koster J; Horlings HM; Meijer SL; van de Vijver MJ
Breast Cancer Res Treat; 2019 Apr; 174(3):649-659. PubMed ID: 30610490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
